Page 8 - V Imaging News Today

Although artificial intelligence is changing the role of the physician, several experts agreed that it is not making cardiologists superfluous.

Study findings are encouraging, but the population was not diverse, and only one dose of atorvastatin was examined.

Results of the DICTATE-AHF randomized trial that tested starting dapagliflozin for patients hospitalized with acute heart failure confirmed the safety and benefit of this guideline-directed strategy.

This is a population that has not gotten a lot of attention, said an expert. Upgrading their pacemakers to a cardiac resynchronization device may be the answer for some.

Prespecified analysis of the STEP-HFpEF trial of semaglutide in people with obesity and heart failure with preserved ejection fraction showed a positive link between weight-loss amounts and outcomes.

Endocarditis can present with many different clinical scenarios, so making the diagnosis can be challenging, says a co-chair of newly issued European guidelines for managing this disease.

In the randomized trial QUEST trial, a traditional Chinese medicine called qiliqiangxin provided significant reductions in CV death and hospitalization on top of guideline-directed therapy in HFrEF.

The trial "should make complete revascularization the standard of care in MI," and advanced age alone "should no longer be considered a contraindication," said an expert.

The largest ever study of IV iron supplementation in patients with heart failure failed to meet a new rigorous definition of significance, and the results were generally regarded as disappointing.

In STEP-HFpEF, a prospective, randomized study of adults with HFpEF and obesity, weekly semaglutide weight-loss injections for 1 year led to substantial improvements in physical function and symptoms.